Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 165

1.

Effects of Depilation-Induced Skin Pigmentation and Diet-Induced Fluorescence on In Vivo Fluorescence Imaging.

Kwon S, Sevick-Muraca EM.

Contrast Media Mol Imaging. 2017 Jun 19;2017:7659242. doi: 10.1155/2017/7659242. eCollection 2017.

2.

Moonshot Acceleration Factor: Medical Imaging.

Sevick-Muraca EM, Frank RA, Giger ML, Mulshine JL.

Cancer Res. 2017 Nov 1;77(21):5717-5720. doi: 10.1158/0008-5472.CAN-17-1698. Epub 2017 Oct 9.

PMID:
28993413
3.

Fluorescence imaging of lymphatic outflow of cerebrospinal fluid in mice.

Kwon S, Janssen CF, Velasquez FC, Sevick-Muraca EM.

J Immunol Methods. 2017 Oct;449:37-43. doi: 10.1016/j.jim.2017.06.010. Epub 2017 Jun 22.

PMID:
28648385
4.

Near-infrared fluorescence lymphatic imaging of Klippel-Trénaunay syndrome.

Rasmussen JC, Zvavanjanja RC, Aldrich MB, Greives MR, Sevick-Muraca EM.

J Vasc Surg Venous Lymphat Disord. 2017 Jul;5(4):533-537. doi: 10.1016/j.jvsv.2017.01.011.

5.

Lymphatic delivery of etanercept via nanotopography improves response to collagen-induced arthritis.

Aldrich MB, Velasquez FC, Kwon S, Azhdarinia A, Pinkston K, Harvey BR, Chan W, Rasmussen JC, Ross RF, Fife CE, Sevick-Muraca EM.

Arthritis Res Ther. 2017 May 31;19(1):116. doi: 10.1186/s13075-017-1323-z.

6.

Near-Infrared Fluorescence Lymphatic Imaging of a Toddler With Congenital Lymphedema.

Greives MR, Aldrich MB, Sevick-Muraca EM, Rasmussen JC.

Pediatrics. 2017 Apr;139(4). pii: e20154456. doi: 10.1542/peds.2015-4456.

7.

Longitudinal monitoring of the head and neck lymphatics in response to surgery and radiation.

Rasmussen JC, Tan IC, Naqvi S, Aldrich MB, Maus EA, Blanco AI, Karni RJ, Sevick-Muraca EM.

Head Neck. 2017 Jun;39(6):1177-1188. doi: 10.1002/hed.24750. Epub 2017 Mar 6.

PMID:
28263428
8.

New diagnostic modalities in the evaluation of lymphedema.

O'Donnell TF Jr, Rasmussen JC, Sevick-Muraca EM.

J Vasc Surg Venous Lymphat Disord. 2017 Mar;5(2):261-273. doi: 10.1016/j.jvsv.2016.10.083. Epub 2017 Jan 16. Review.

9.

Fluid shear stress activates YAP1 to promote cancer cell motility.

Lee HJ, Diaz MF, Price KM, Ozuna JA, Zhang S, Sevick-Muraca EM, Hagan JP, Wenzel PL.

Nat Commun. 2017 Jan 18;8:14122. doi: 10.1038/ncomms14122.

10.

Antibody Guided Molecular Imaging of Infective Endocarditis.

Pinkston KL, Gao P, Singh KV, Azhdarinia A, Murray BE, Sevick-Muraca EM, Harvey BR.

Methods Mol Biol. 2017;1535:229-241.

PMID:
27914083
11.

Effect of lidocaine with and without epinephrine on lymphatic contractile activity in mice in vivo.

Kwon S, Sevick-Muraca EM.

J Anesth. 2016 Dec;30(6):1091-1094. doi: 10.1007/s00540-016-2260-8. Epub 2016 Oct 11.

12.

Lymphatic transport in patients with chronic venous insufficiency and venous leg ulcers following sequential pneumatic compression.

Rasmussen JC, Aldrich MB, Tan IC, Darne C, Zhu B, O'Donnell TF Jr, Fife CE, Sevick-Muraca EM.

J Vasc Surg Venous Lymphat Disord. 2016 Jan;4(1):9-17. doi: 10.1016/j.jvsv.2015.06.001. Epub 2015 Jul 16.

13.

A novel mutation in CELSR1 is associated with hereditary lymphedema.

Gonzalez-Garay ML, Aldrich MB, Rasmussen JC, Guilliod R, Lapinski PE, King PD, Sevick-Muraca EM.

Vasc Cell. 2016 Feb 5;8:1. doi: 10.1186/s13221-016-0035-5. eCollection 2016.

14.

Determining the Performance of Fluorescence Molecular Imaging Devices Using Traceable Working Standards With SI Units of Radiance.

Zhu B, Rasmussen JC, Litorja M, Sevick-Muraca EM.

IEEE Trans Med Imaging. 2016 Mar;35(3):802-11. doi: 10.1109/TMI.2015.2496898. Epub 2015 Nov 3.

15.

Longitudinal far red gene-reporter imaging of cancer metastasis in preclinical models: a tool for accelerating drug discovery.

Zhu B, Robinson H, Zhang S, Wu G, Sevick-Muraca EM.

Biomed Opt Express. 2015 Aug 13;6(9):3346-51. doi: 10.1364/BOE.6.003346. eCollection 2015 Sep 1.

16.

Near-infrared fluorescence lymphatic imaging in a patient treated for venous occlusion.

Rasmussen JC, Aldrich MB, Guilliod R, Fife CE, O'Donnell TF, Sevick-Muraca EM.

J Vasc Surg Cases. 2015 Sep;1(3):201-204. doi: 10.1016/j.jvsc.2015.05.004.

17.

Near-Infrared Fluorescence Lymphatic Imaging in Lymphangiomatosis.

Rasmussen JC, Fife CE, Sevick-Muraca EM.

Lymphat Res Biol. 2015 Sep;13(3):195-201. doi: 10.1089/lrb.2015.0013. Epub 2015 Aug 19.

18.

Preclinical characterization and validation of a dual-labeled trastuzumab-based imaging agent for diagnosing breast cancer.

Wang X, Aldrich MB, Marshall MV, Sevick-Muraca EM.

Chin J Cancer Res. 2015 Feb;27(1):74-82. doi: 10.3978/j.issn.1000-9604.2015.01.02.

19.

Comparison of DOTA and NODAGA as chelators for (64)Cu-labeled immunoconjugates.

Ghosh SC, Pinkston KL, Robinson H, Harvey BR, Wilganowski N, Gore K, Sevick-Muraca EM, Azhdarinia A.

Nucl Med Biol. 2015 Feb;42(2):177-83. doi: 10.1016/j.nucmedbio.2014.09.009. Epub 2014 Oct 5.

PMID:
25457653
20.

Experimental Comparison of Continuous-Wave and Frequency-Domain Fluorescence Tomography in a Commercial Multi-Modal Scanner.

Lu Y, Darne CD, Tan IC, Zhu B, Rightmer R, Rasmussen JC, Sevick-Muraca EM.

IEEE Trans Med Imaging. 2015 Jun;34(6):1197-211. doi: 10.1109/TMI.2014.2375193. Epub 2014 Nov 26.

PMID:
25438307
21.

A review of performance of near-infrared fluorescence imaging devices used in clinical studies.

Zhu B, Sevick-Muraca EM.

Br J Radiol. 2015 Jan;88(1045):20140547. doi: 10.1259/bjr.20140547. Review.

22.

Evidence for SH2 domain-containing 5'-inositol phosphatase-2 (SHIP2) contributing to a lymphatic dysfunction.

Agollah GD, Gonzalez-Garay ML, Rasmussen JC, Tan IC, Aldrich MB, Darne C, Fife CE, Guilliod R, Maus EA, King PD, Sevick-Muraca EM.

PLoS One. 2014 Nov 10;9(11):e112548. doi: 10.1371/journal.pone.0112548. eCollection 2014.

23.

In vivo lymphatic imaging of a human inflammatory breast cancer model.

Agollah GD, Wu G, Sevick-Muraca EM, Kwon S.

J Cancer. 2014 Oct 23;5(9):774-83. doi: 10.7150/jca.9835. eCollection 2014.

24.

Spatio-temporal changes of lymphatic contractility and drainage patterns following lymphadenectomy in mice.

Kwon S, Agollah GD, Wu G, Sevick-Muraca EM.

PLoS One. 2014 Aug 29;9(8):e106034. doi: 10.1371/journal.pone.0106034. eCollection 2014.

25.

Deglycosylation of mAb by EndoS for improved molecular imaging.

Gao P, Pinkston KL, Wilganowski N, Robinson H, Azhdarinia A, Zhu B, Sevick-Muraca EM, Harvey BR.

Mol Imaging Biol. 2015 Apr;17(2):195-203. doi: 10.1007/s11307-014-0781-9.

PMID:
25135058
26.

An abnormal lymphatic phenotype is associated with subcutaneous adipose tissue deposits in Dercum's disease.

Rasmussen JC, Herbst KL, Aldrich MB, Darne CD, Tan IC, Zhu B, Guilliod R, Fife CE, Maus EA, Sevick-Muraca EM.

Obesity (Silver Spring). 2014 Oct;22(10):2186-92. doi: 10.1002/oby.20836. Epub 2014 Jul 9.

27.

Investigational lymphatic imaging at the bedside in a pediatric postoperative chylothorax patient.

Tan IC, Balaguru D, Rasmussen JC, Guilliod R, Bricker JT, Douglas WI, Sevick-Muraca EM.

Pediatr Cardiol. 2014 Oct;35(7):1295-300. doi: 10.1007/s00246-014-0946-y. Epub 2014 Jun 28.

28.

Stable confinement of positron emission tomography and magnetic resonance agents within carbon nanotubes for bimodal imaging.

Cisneros BT, Law JJ, Matson ML, Azhdarinia A, Sevick-Muraca EM, Wilson LJ.

Nanomedicine (Lond). 2014 Nov;9(16):2499-509. doi: 10.2217/nnm.14.26.

29.

Emerging lymphatic imaging technologies for mouse and man.

Sevick-Muraca EM, Kwon S, Rasmussen JC.

J Clin Invest. 2014 Mar;124(3):905-14. doi: 10.1172/JCI71612. Epub 2014 Mar 3. Review.

30.

Non-invasive fluorescence imaging under ambient light conditions using a modulated ICCD and laser diode.

Zhu B, Rasmussen JC, Sevick-Muraca EM.

Biomed Opt Express. 2014 Jan 24;5(2):562-72. doi: 10.1364/BOE.5.000562. eCollection 2014 Feb 1.

31.
32.

Toward nodal staging of axillary lymph node basins through intradermal administration of fluorescent imaging agents.

Meric-Bernstam F, Rasmussen JC, Krishnamurthy S, Tan IC, Zhu B, Wagner JL, Babiera GV, Mittendorf EA, Sevick-Muraca EM.

Biomed Opt Express. 2013 Dec 13;5(1):183-96. doi: 10.1364/BOE.5.000183. eCollection 2013 Dec 13.

33.

Targeting pili in enterococcal pathogenesis.

Pinkston KL, Singh KV, Gao P, Wilganowski N, Robinson H, Ghosh S, Azhdarinia A, Sevick-Muraca EM, Murray BE, Harvey BR.

Infect Immun. 2014 Apr;82(4):1540-7. doi: 10.1128/IAI.01403-13. Epub 2014 Jan 22.

34.

Small animal fluorescence and bioluminescence tomography: a review of approaches, algorithms and technology update.

Darne C, Lu Y, Sevick-Muraca EM.

Phys Med Biol. 2014 Jan 6;59(1):R1-64. doi: 10.1088/0031-9155/59/1/R1. Epub 2013 Dec 16. Review.

PMID:
24334634
35.

Lymphatic vessel abnormalities arising from disorders of Ras signal transduction.

Sevick-Muraca EM, King PD.

Trends Cardiovasc Med. 2014 Apr;24(3):121-7. doi: 10.1016/j.tcm.2013.09.004. Epub 2013 Nov 1. Review.

36.

Far-red fluorescence gene reporter tomography for determination of placement and viability of cell-based gene therapies.

Lu Y, Darne CD, Tan IC, Zhu B, Hall MA, Lazard ZW, Davis AR, Simpson L, Sevick-Muraca EM, Olmsted-Davis EA.

Opt Express. 2013 Oct 7;21(20):24129-38. doi: 10.1364/OE.21.024129.

37.

Lymphatic vascular response to acute inflammation.

Lachance PA, Hazen A, Sevick-Muraca EM.

PLoS One. 2013 Sep 27;8(9):e76078. doi: 10.1371/journal.pone.0076078. eCollection 2013.

38.

In vivo imaging of orthotopic prostate cancer with far-red gene reporter fluorescence tomography and in vivo and ex vivo validation.

Lu Y, Darne CD, Tan IC, Wu G, Wilganowski N, Robinson H, Azhdarinia A, Zhu B, Rasmussen JC, Sevick-Muraca EM.

J Biomed Opt. 2013 Oct;18(10):101305. doi: 10.1117/1.JBO.18.10.101305.

39.

Cytokines are systemic effectors of lymphatic function in acute inflammation.

Aldrich MB, Sevick-Muraca EM.

Cytokine. 2013 Oct;64(1):362-9. doi: 10.1016/j.cyto.2013.05.015. Epub 2013 Jun 10.

40.

Direct visualization of changes of lymphatic function and drainage pathways in lymph node metastasis of B16F10 melanoma using near-infrared fluorescence imaging.

Kwon S, Agollah GD, Wu G, Chan W, Sevick-Muraca EM.

Biomed Opt Express. 2013 May 30;4(6):967-77. doi: 10.1364/BOE.4.000967. Print 2013 Jun 1.

41.

Detection of lymphangiogenesis by near-infrared fluorescence imaging and responses to VEGF-C during healing in a mouse full-dermis thickness wound model.

Hall MA, Robinson H, Chan W, Sevick-Muraca EM.

Wound Repair Regen. 2013 Jul-Aug;21(4):604-15. doi: 10.1111/wrr.12063. Epub 2013 Jun 11.

PMID:
23758174
42.

Lymphatic abnormalities are associated with RASA1 gene mutations in mouse and man.

Burrows PE, Gonzalez-Garay ML, Rasmussen JC, Aldrich MB, Guilliod R, Maus EA, Fife CE, Kwon S, Lapinski PE, King PD, Sevick-Muraca EM.

Proc Natl Acad Sci U S A. 2013 May 21;110(21):8621-6. doi: 10.1073/pnas.1222722110. Epub 2013 May 6.

43.

Tumor margin detection using quantitative NIRF molecular imaging targeting EpCAM validated by far red gene reporter iRFP.

Zhu B, Wu G, Robinson H, Wilganowski N, Hall MA, Ghosh SC, Pinkston KL, Azhdarinia A, Harvey BR, Sevick-Muraca EM.

Mol Imaging Biol. 2013 Oct;15(5):560-8. doi: 10.1007/s11307-013-0637-8.

PMID:
23619897
44.

The need for performance standards in clinical translation and adoption of fluorescence molecular imaging.

Sevick-Muraca EM, Zhu B.

Med Phys. 2013 Apr;40(4):040402. doi: 10.1118/1.4789499. No abstract available.

45.

Non-invasive optical imaging of the lymphatic vasculature of a mouse.

Robinson HA, Kwon S, Hall MA, Rasmussen JC, Aldrich MB, Sevick-Muraca EM.

J Vis Exp. 2013 Mar 8;(73):e4326. doi: 10.3791/4326.

46.

Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology.

Prabhakar U, Maeda H, Jain RK, Sevick-Muraca EM, Zamboni W, Farokhzad OC, Barry ST, Gabizon A, Grodzinski P, Blakey DC.

Cancer Res. 2013 Apr 15;73(8):2412-7. doi: 10.1158/0008-5472.CAN-12-4561. Epub 2013 Feb 19.

47.

Advancing the translation of optical imaging agents for clinical imaging.

Sevick-Muraca EM, Akers WJ, Joshi BP, Luker GD, Cutler CS, Marnett LJ, Contag CH, Wang TD, Azhdarinia A.

Biomed Opt Express. 2013 Jan 1;4(1):160-70. doi: 10.1364/BOE.4.000160. Epub 2012 Dec 18.

48.

Altered lymphatic function and architecture in salt-induced hypertension assessed by near-infrared fluorescence imaging.

Kwon S, Agollah GD, Chan W, Sevick-Muraca EM.

J Biomed Opt. 2012 Aug;17(8):080504-1. doi: 10.1117/1.JBO.17.8.080504. Erratum in: J Biomed Opt. 2012 Aug;17(8):089802.

49.

Multimodal chelation platform for near-infrared fluorescence/nuclear imaging.

Ghosh SC, Ghosh P, Wilganowski N, Robinson H, Hall MA, Dickinson G, Pinkston KL, Harvey BR, Sevick-Muraca EM, Azhdarinia A.

J Med Chem. 2013 Jan 24;56(2):406-16. doi: 10.1021/jm300906g. Epub 2013 Jan 8.

PMID:
23214723
50.

A compact frequency-domain photon migration system for integration into commercial hybrid small animal imaging scanners for fluorescence tomography.

Darne CD, Lu Y, Tan IC, Zhu B, Rasmussen JC, Smith AM, Yan S, Sevick-Muraca EM.

Phys Med Biol. 2012 Dec 21;57(24):8135-52. doi: 10.1088/0031-9155/57/24/8135. Epub 2012 Nov 22.

Supplemental Content

Loading ...
Support Center